Spontaneous Breathing Trials in Mechanically Ventilated Patients

Introduction to Spontaneous Breathing Trials

The American Thoracic Society recommends that all mechanically ventilated patients who meet readiness criteria should undergo a daily spontaneous breathing trial to determine their ability to breathe unassisted and reduce the duration of mechanical ventilation 1, 2, 3

Patients should meet all of the following criteria: FiO₂ < 0.50, PEEP ≤ 5 cmH₂O, hemodynamic stability, adequate mental status, intact airway reflexes, resolution or improvement of the primary indication for mechanical ventilation, and no new potentially serious conditions 1, 2, 3, 4, 5

The initial SBT should be conducted with modest inspiratory pressure support (5-8 cmH₂O) rather than T-piece alone, as this approach has demonstrated superior outcomes 2, 3
SBT success rate: 84.6% with pressure support vs. 76.7% with T-piece 2, 3
Extubation success rate: 75.4% with pressure support vs. 68.9% with T-piece 2, 3

Standard-risk patients require a 30-minute SBT, which is sufficient to assess readiness for extubation in most cases 2, 3
High-risk patients should undergo a 60-120 minute SBT for more accurate prediction of extubation success 1, 2, 3
The SBT should be terminated immediately if the patient shows signs of respiratory distress, hemodynamic instability, oxygen desaturation, altered mental status, or diaphoresis 2, 3

For patients at high risk of extubation failure who pass an SBT, use prophylactic noninvasive ventilation (NIV) immediately after extubation rather than standard oxygen therapy 6, 3
High-risk features include prolonged mechanical ventilation (>14 days), chronic lung disease, myocardial dysfunction, neurologic impairment, previously failed extubation, and ineffective cough or impaired bulbar function 2, 6
For hypercapnic respiratory failure, particularly in COPD patients, NIV facilitates weaning with decreased mortality (RR 0.54) and reduced weaning failure (RR 0.61) 3